Parkinson's DiseaseFDA Approved Clinical Trial for Bradykinesia due to Parkinson's Disease.
As Tennessee’s only regenerative medicine practice with an FDA approved clinical trial, IMAC Regeneration Centers combine life science advancements with traditional medical care for movement restricting diseases and conditions.
IMAC is enrolling patients in our FDA approved clinical trial for bradykinesia due to Parkinson’s Disease. The clinical trial is offered free of charge to patients that meet the selection criteria approved by the FDA.
If you or a loved one are interested in the IMAC Regeneration FDA Approved Clinical Trial Program for Bradykinesia due to Parkinson’s Disease, please complete the form below. Your information will be review by our medical team.
Debbie Hepler was a typical Parkinson’s patient suffering terribly from damaging, incurable neurological condition and was getting worse each day. She was only able to make little shuffle steps and couldn’t do more than get up, look at the television and read. In her 6th month of treatment at IMAC Regeneration she began writing legibly and walking without a cane !
Dr. Rachel Rome, M.D.
Rachel Rome, MD, is an anesthesiologist and interventional pain management specialist. Though she hails from the New Orleans area, she has been providing multidisciplinary treatments for patients in the surrounding Nashville area for over 8 years. She is passionate about providing comprehensive individualized care and focuses on educating patients on the specialized medical treatment options at IMAC Regeneration.
Committed to Success without surgery.